GNLN Form 4: 315,000 options at $3.84; 5,000 shares granted
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Greenlane Holdings (GNLN) reported an insider equity grant. On 10/20/2025, a Director acquired 5,000 shares of Class A common stock at $0.00 as restricted stock under the 2019 Equity Incentive Plan. The filing also reports a grant of 315,000 stock options at an exercise price of $3.84, vesting in full upon grant and expiring on 10/20/2030.
Following these transactions, the Director beneficially owns 5,000 shares and 315,000 options. The option grant was allocated from the Company’s 3,000,000-share ESOP distribution approved by the Board on 10/14/2025.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
HOWE MICHAEL C
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 315,000 | $0.001 | $315.00 |
| Grant/Award | Class A Common Stock | 5,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 315,000 shares (Direct);
Class A Common Stock — 5,000 shares (Direct)
Footnotes (1)
- Represents shares of restricted stock issued as compensatory equity under the Company's 2019 Equity Incentive Plan. The exercise price equals the closing price of Greenlane Holdings, Inc. Class A Common Stock on October 17, 2025. Options vest in full upon grant in consideration of executive service and expire five (5) years from the grant date, unless earlier terminate dunder Plan terms. The option allocation is from the Company's 3,000,000 share ESOP distribution approved and ratified by the Board on October 14, 2025.
FAQ
What insider transaction did GNLN report on Form 4?
A Director received 5,000 restricted shares at $0.00 and 315,000 stock options at a $3.84 exercise price on 10/20/2025.
How many securities does the reporting person own after the transactions for GNLN?
The filing lists 5,000 Class A shares and 315,000 stock options as beneficially owned.
What are the key terms of the GNLN option grant?
315,000 options at a $3.84 exercise price, vesting in full upon grant, with an expiration date of 10/20/2030.
What is the source of the GNLN option allocation?
The options came from a 3,000,000-share ESOP distribution approved and ratified by the Board on 10/14/2025.